Biolase (BIOL) Misses Q2 EPS by 4c

Biolase (NASDAQ: BIOL) reported Q2 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $12.3 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Movano (MOVE) Misses Q2 EPS by 195c